MPG.eBooks - Staff View: CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.)

Read Now

Bibliographic Details
Corporate Author:	CADTH Canadian Drug Expert Committee
Format:	eBook
Language:	English
Published:	Ottawa (ON) CADTH October 2019, 2019
Edition:	Version 1.0
Series:	CADTH common drug review
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK564614
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa


LEADER	00940nam a2200241 u 4500
001	EB002010789
003	EBX01000000000000001173688
005	00000000000000.0
007	tu\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|
008	220201 r \|\|\| eng
245	0	0	\|a CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) \|h Elektronische Ressource \|b indication: chronic migraine
246	3	1	\|a Onabotulinumtoxin A (Botox -- Allergan Inc.)
246	3	1	\|a Drug reimbursement recommendation Onabotulinumtoxin A (Botox)
250			\|a Version 1.0
260			\|a Ottawa (ON) \|b CADTH \|c October 2019, 2019
300			\|a 1 PDF file (13 pages)
710	2		\|a CADTH Canadian Drug Expert Committee
041	0	7	\|a eng \|2 ISO 639-2
989			\|b NCBI \|a National Center for Biotechnology Information
490	0		\|a CADTH common drug review
856	4	0	\|u https://www.ncbi.nlm.nih.gov/books/NBK564614 \|3 Volltext
082	0		\|a 610
082	0		\|a 330